Supplement References

Supplement References

<p>SUPPLEMENT REFERENCES</p><p>38. Aghokeng, A.F., et al., Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2004. 37(5): p. 1632-40. 39. Aghokeng, A.F., et al., Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS ONE [Electronic Resource], 2009. 4(11): p. e7702. 40. Anzala, O., et al., Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East African Medical Journal, 2008. 85(10): p. 500-4. 41. Ashby, J., et al., HIV testing uptake and acceptability in an inner city polyclinic. AIDS Care, 2012. 24(7): p. 905-909. 42. Bajunirwe, F. and M. Muzoora, Barriers to the implementation of programs for the prevention of mother-to-child transmission of HIV: A cross-sectional survey in rural and urban Uganda. AIDS Research and Therapy, 2005. 2(1). 43. Bakari, J.P., et al., Rapid voluntary testing and counseling for HIV: Acceptability and feasibility in Zambian antenatal care clinics. 2000, New York Academy of Sciences. p. 64- 76. 44. Banwat, E.B., J.Y. Peter, and D.Z. Egah, Evaluation of commercial HIV test kits used in Nigeria. Nigerian Journal of Clinical Practice, 2009. 12(1): p. 11-4. 45. Bass, M.G., et al., Provider and practice characteristics associated with use of rapid HIV Testing by general internists. Journal of General Internal Medicine, 2011. 26(11): p. 1258-64. 46. Bassett, I.V., et al., Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Medicine, 2011. 12(1): p. 46-53. 47. Beckwith, C.G., et al., An evaluation of a routine opt-out rapid HIV testing program in a Rhode Island jail. AIDS Education & Prevention, 2011. 23(3 Suppl): p. 96-109. 48. Bienek, D.R. and D.G. Charlton, The effect of simulated field storage conditions on the accuracy of rapid user-friendly blood pathogen detection kits. Military Medicine, 2012. 177(5): p. 583-8. 49. Black, V., et al., Poor sensitivity of field rapid HIV testing: implications for mother-to- child transmission programme. BJOG: An International Journal of Obstetrics & Gynaecology, 2009. 116(13): p. 1805-8. 50. Bogart, L.M., et al., Scope of rapid HIV testing in private nonprofit urban community health settings in the United States. American Journal of Public Health, 2008. 98(4): p. 736-42. 51. Brown, J., et al., Routine HIV screening in the emergency department using the new US Centers for Disease Control and Prevention Guidelines: results from a high-prevalence area. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2007. 46(4): p. 395-401. 52. Brown, J., et al., Another look at Emergency Department HIV screening in practice: No need to revise expectations. AIDS Research and Therapy, 2010. 7(1). 53. Bruzzone, B., et al., HIV serological screening in a population of pregnant women in the Republic of Congo: suitability of different assays. Tropical Medicine & International Health, 2008. 13(7): p. 900-3. 54. Burgess-Cassler, A., et al., A field test for the detection of antibodies to human immunodeficiency virus types 1 and 2 in serum or plasma. Clinical & Diagnostic Laboratory Immunology, 1996. 3(4): p. 480-482. 55. Cabie, A., et al., Impact of rapid HIV testing on the return rate for routine test results in sexually transmitted infection testing centres. International Journal of STD & AIDS, 2011. 22(12): p. 757-8. 56. Cadoff, E.M., et al., Integrating rapid HIV testing in emergency care improves HIV detection. Point of Care, 2007. 6(3): p. 201-207. 57. Centers for Disease, C. and Prevention, False-positive oral fluid rapid HIV tests--New York City, 2005-2008. MMWR - Morbidity & Mortality Weekly Report, 2008. 57(24): p. 660-5. 58. Chetty, V., D. Moodley, and A. Chuturgoon, Evaluation of a 4th generation rapid HIV test for earlier and reliable detection of HIV infection in pregnancy. Journal of Clinical Virology, 2012. 54(2): p. 180-4. 59. Claassen, M., et al., Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa. Journal of Clinical Virology, 2006. 37(1): p. 68-71. 60. Constantine, N.T., et al., Diagnostic challenges for rapid human immunodeficiency virus assays. Performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples. Journal of Human Virology, 1997. 1(1): p. 45-51. 61. Cook, N. and B. Dattel, The role of the rapid HIV test in women with no prenatal care. Primary Care Update for Ob/Gyns, 1999. 6(6): p. 202-204. 62. Crucitti, T., et al., Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial. Clinical & Vaccine Immunology: CVI, 2011. 18(9): p. 1480-5. 63. Delaney, K.P., et al., Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS, 2006. 20(12): p. 1655-60. 64. Dickson-Gomez, J., et al., Resources and obstacles to developing and implementing a structural intervention to prevent HIV in San Salvador, El Salvador. Social Science and Medicine, 2010. 70(3): p. 351-359. 65. Ehrenkranz, P.D., et al., Availability of rapid human immunodeficiency virus testing in academic emergency departments. Academic Emergency Medicine, 2008. 15(2): p. 144- 50. 66. Eller, L.A., et al., Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population. Journal of Clinical Microbiology, 2007. 45(10): p. 3281-3285. 67. Facente, S.N., et al., False positive rate of rapid oral fluid HIV tests increases as kits near expiration date. PLoS ONE [Electronic Resource], 2009. 4(12): p. e8217. 68. Farnham, P.G., et al., Comparing the costs of HIV screening strategies and technologies in health-care settings. Public Health Reports, 2008. 123 Suppl 3: p. 51-62. 69. Forsyth, S.F., et al., Would offering rapid point-of-care testing or non-invasive methods improve uptake of HIV testing among high-risk genitourinary medicine clinic attendees? A patient perspective. International Journal of STD & AIDS, 2008. 19(8): p. 550-2. 70. Garg, N., et al., Comparison of salivary and serum antibody detection in HIV-1 infection by ELISA and rapid methods in India. Tropical Doctor, 2006. 36(2): p. 108-9. 71. Gaur, S., et al., Disparity in hospital utilization of rapid HIV-1 testing for women in labor with undocumented HIV status. Maternal & Child Health Journal, 2010. 14(2): p. 268-73. 72. Gay, C.L., et al., Acute HIV infection among pregnant women in Malawi. Diagnostic Microbiology & Infectious Disease, 2010. 66(4): p. 356-360. 73. Gaydos, C.A., et al., Will patients "opt in" to perform their own rapid HIV test in the emergency department? Annals of Emergency Medicine, 2011. 58(1 Suppl 1): p. S74-8. 74. Giles, R.E., K.R. Perry, and J.V. Parry, Simple/rapid test devices for anti-HIV screening: do they come up to the mark? Journal of Medical Virology, 1999. 59(1): p. 104-9. 75. Gottfried, T.D., R.W. Mink, and P. Phanuphak, Calypte AWARE HIV-1/2 OMT antibody test using oral fluid: special challenges of rapid HIV testing in the developing world. Expert Review of Molecular Diagnostics, 2006. 6(2): p. 139-44. 76. Gray, R.H., et al., Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ, 2007. 335(7612): p. 188-190. 77. Guenter, D., et al., Rapid point-of-care HIV testing in community-based anonymous testing program: a valuable alternative to conventional testing. AIDS Patient Care & Stds, 2008. 22(3): p. 195-204. 78. Haddow, L.J. and A.J. Robinson, A case of a false positive result on a home HIV test kit obtained on the internet. Sexually Transmitted Infections, 2005. 81(4): p. 359. 79. Hamers, R.L., et al., Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2008. 48(1): p. 116- 8. 80. Heller, T., et al., Point-of-care HIV testing at antenatal care and maternity sites: experience in Battambang Province, Cambodia. International Journal of STD & AIDS, 2011. 22(12): p. 742-7. 81. Henning, M.P., C. Kruger, and L. Fletcher, HIV sero-positivity in recently admitted and long-term psychiatric in-patients: Prevalence and diagnostic profile. African Journal of Psychiatry (South Africa), 2012. 15(1): p. 47-53. 82. Herbert, R., et al., Nurse-delivered universal point-of-care testing for HIV in an open- access returning traveller clinic. HIV Medicine, 2012. 13(8): p. 499-504. 83. Holguin, A., Evaluation of three rapid tests for detection of antibodies to HIV-1 non-B subtypes. Journal of Virological Methods, 2004. 115(1): p. 105-7. 84. Holguin, A., et al., Performance of OraQuick Advance Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. Journal of Clinical Virology, 2009. 45(2): p. 150-2. 85. Indrati, A.R., et al., Screening and diagnosis of HIV-infection in Indonesia: one, two or three tests? Acta Medica Indonesiana, 2009. 41 Suppl 1: p. 28-32. 86. Irwin, K., et al., Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. CDC-Bronx-Lebanon HIV Serosurvey Team. Annals of Internal Medicine, 1996. 125(6): p. 471-475. 87. Jafa, K., et al., Investigation of false positive results with an oral fluid rapid HIV-1/2 antibody test. PLoS ONE [Electronic Resource], 2007. 2(1): p. e185. 88. Jain, S., et al., Seroprevalence study using oral rapid HIV testing in a large urban emergency department. Journal of Emergency Medicine, 2012. 43(5): p. e269-75. 89. Jamieson, D.J., et al., Rapid human immunodeficiency virus-1 testing on labor and delivery in 17 US hospitals: the MIRIAD experience. American Journal of Obstetrics & Gynecology, 2007. 197(3 Suppl): p. S72-82. 90. Jereni, B.H. and A.S. Muula, Availability of supplies and motivations for accessing voluntary HIV counseling and testing services in Blantyre, Malawi. BMC Health Services Research, 2008. 8: p. 17. 91. Joseph, H.A., et al., "The anticipation alone could kill you": past and potential clients' perspectives on HIV testing in non-health care settings. AIDS Education & Prevention, 2011. 23(6): p. 577-94. 92. Kagulire, S.C., et al., Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda. International Journal of STD & AIDS, 2011. 22(6): p. 308-9. 93. Kaur, H., J. Dhanao, and A. Oberoi, Evaluation of rapid kits for detection of HIV, HBsAg and HCV infections. Indian Journal of Medical Sciences, 2000. 54(10): p. 432-4. 94. Keenan, P.A. and J.M. Keenan, Rapid hiv testing in urban outreach: a strategy for improving posttest counseling rates. AIDS Education & Prevention, 2001. 13(6): p. 541- 50. 95. Kelley, C.E., et al., Toward elimination of perinatal HIV transmission: New Jersey hospital barriers to rapid HIV testing in labor and delivery, 2005. Public Health Reports, 2011. 126(1): p. 145-52. 96. Ketema, F., et al., Assessment of the performance of a rapid, lateral flow assay for the detection of antibodies to HIV. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2001. 27(1): p. 63-70. 97. Kilembe, W., et al., Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection. PLoS ONE [Electronic Resource], 2012. 7(6): p. Article No. e37154. 98. Klarkowski, D.B., et al., The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS ONE [Electronic Resource], 2009. 4(2): p. e4351. 99. Kroc, K. and D. Howerton, Report of a survey of ASCP members concerning point-of-care rapid HIV testing and the clinical laboratory. Laboratory Medicine, 2005. 36(8): p. 468- 469. 100. Kroidl, I., et al., Low Specificity of Determine HIV1/2 RDT Using Whole Blood in South West Tanzania. PLoS ONE [Electronic Resource], 2012. 7(6): p. Article No. e39529. 101. Laforgerie, E., et al., Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. Journal of Virological Methods, 2010. 165(1): p. 105-107. 102. Learmonth, K.M., et al., Assessing proficiency of interpretation of rapid human immunodeficiency virus assays in nonlaboratory settings: ensuring quality of testing. Journal of Clinical Microbiology, 2008. 46(5): p. 1692-7. 103. Lee, V.J., et al., User acceptability and feasibility of self-testing with HIV rapid tests. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2007. 45(4): p. 449-53. 104. Lejon, V., et al., Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. Journal of Clinical Microbiology, 2010. 48(8): p. 2836-9. 105. Lyamuya, E.F., et al., Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infectious Diseases, 2009. 9: p. 19. 106. MacPherson, P., et al., Feasibility and acceptability of point of care HIV testing in community outreach and GUM drop-in services in the North West of England: a programmatic evaluation. BMC Public Health, 2011. 11: p. 419. 107. Makuwa, M., et al., Reliability of rapid diagnostic tests for HIV variant infection. Journal of Virological Methods, 2002. 103(2): p. 183-90. 108. Maree, L., et al., Young age a predictor of weak reactivity in a rapid antibody test in infants infected with HIV. Journal of Medical Virology, 2010. 82(8): p. 1314-7. 109. Matemo, D., et al., Indeterminate rapid HIV-1 test results among antenatal and postnatal mothers. International Journal of STD & AIDS, 2009. 20(11): p. 790-2. 110. Mayhood, M.K., et al., Validation, performance under field conditions, and cost- effectiveness of Capillus HIV-1/HIV-2 and determine HIV-1/2 rapid human immunodeficiency virus antibody assays using sequential and parallel testing algorithms in Tanzania. Journal of Clinical Microbiology, 2008. 46(12): p. 3946-3951. 111. Merchant, R.C., et al., Emergency department patient perceptions and preferences on opt-in rapid HIV screening program components. AIDS Care, 2009. 21(4): p. 490-500. 112. Mfinanga, G.S., et al., Quality of HIV laboratory testing in Tanzania: a situation analysis. Tanzania Health Research Bulletin, 2007. 9(1): p. 44-7. 113. Millett, G.A., et al., Mistaken assumptions and missed opportunities: Correlates of undiagnosed HIV infection among black and Latino men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 2011. 58(1): p. 64-71. 114. Moodley, D., et al., Reliability of HIV rapid tests is user dependent. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde, 2008. 98(9): p. 707-9. 115. Myers, J.J., et al., Routine rapid HIV screening in six community health centers serving populations at risk.[Erratum appears in J Gen Intern Med. 2010 Mar;25(3):277]. Journal of General Internal Medicine, 2009. 24(12): p. 1269-74. 116. Nogueira, S.A., et al., Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, Brazil. Journal of Human Virology, 2001. 4(5): p. 278-82. 117. O'Connell, R.J., et al., Sensitivity of the multispot HIV-1/HIV-2 rapid test using samples from human immunodeficiency virus type 1-positive individuals with various levels of exposure to highly active antiretroviral therapy. Journal of Clinical Microbiology, 2006. 44(5): p. 1831-1833. 118. Oswalt, S., et al., Need for HIV home testing kit option and education. Journal of College Student Development, 1998. 39(6): p. 627-629. 119. Pavie, J., et al., Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS ONE [Electronic Resource], 2010. 5(7): p. e11581. 120. Phillips, S., et al., Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clinical & Diagnostic Laboratory Immunology, 2000. 7(4): p. 698-9. 121. Pinkerton, S.D., et al., Cost of rapid HIV testing at 45 U.S. hospitals. AIDS Patient Care & Stds, 2010. 24(7): p. 409-13. 122. Plourde, P.J., et al., Accuracy and costs of rapid human immunodeficiency virus testing technologies in rural hospitals in Zambia. Sexually Transmitted Diseases, 1998. 25(5): p. 254-259. 123. Ray, C.S., et al., An evaluation of dipstick-dot immunoassay in the detection of antibodies to HIV-1 and 2 in Zimbabwe. Tropical Medicine & International Health, 1997. 2(1): p. 83-8. 124. Rexroth, K., K. Hare, and V.L. Kan, Rapid oral HIV screening: expectations revisited. Journal of Acquired Immune Deficiency Syndromes: JAIDS, 2011. 56(2): p. e59-60. 125. Ruutel, K., V. Ustina, and R.D. Parker, Piloting HIV rapid testing in community-based settings in Estonia. Scandinavian Journal of Public Health, 2012. 40(7): p. 629-33. 126. Samdal, H.H., et al., Comparison of the sensitivity of four rapid assays for the detection of antibodies to HIV-1/HIV-2 during seroconversion. Clinical & Diagnostic Virology, 1996. 7(1): p. 55-61. 127. Santos, A., et al., Evaluation of the diagnostic performance of the rapid test VIKIA HIV1/2 in a highly complex HIV-1 epidemic. Diagnostic Microbiology & Infectious Disease, 2011. 71(1): p. 90-2. 128. Sherman, G.G., G.A. Driver, and A.H. Coovadia, Evaluation of seven rapid HIV tests to detect HIV-exposure and seroreversion during infancy. Journal of Clinical Virology, 2008. 43(3): p. 313-6. 129. Sherman, G.G., R.R. Lilian, and A.H. Coovadia, Oral fluid tests for screening of human immunodeficiency virus-exposed infants. Pediatric Infectious Disease Journal, 2010. 29(2): p. 169-72. 130. Spielberg, F., et al., Overcoming barriers to HIV testing: Preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic, and sex venues for men who have sex with men. JAIDS Journal of Acquired Immune Deficiency Syndromes, 2003. 32(3): p. 318-327. 131. Stetler, H.C., et al., Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS, 1997. 11(3): p. 369-75. 132. Sy, F.S., et al., The acceptability of oral fluid testing for HIV antibodies. A pilot study in gay bars in a predominantly rural state. Sexually Transmitted Diseases, 1998. 25(4): p. 211-5. 133. Tepper, N.K., et al., Rapid human immunodeficiency virus testing in obstetric outpatient settings: the MIRIAD study. American Journal of Obstetrics & Gynecology, 2009. 201(1): p. 31.e1-6. 134. Trottier, B., et al., Sensitivity and specificity of rapid HIV testing in a community setting. Sexually Transmitted Infections, 2011. 87: p. A288. 135. van den Berk, G.E., et al., Evaluation of the rapid immunoassay determine HIV 1/2 for detection of antibodies to human immunodeficiency virus types 1 and 2. J Clin Microbiol, 2003. 41(8): p. 3868-9. 136. Watt, G., P. Chanbancherd, and A.E. Brown, Human immunodeficiency virus type 1 test results in patients with malaria and dengue infections. Clinical Infectious Diseases, 2000. 30(5): p. 819. 137. Webber, D.W. and L.O. Gostin, Discrimination based on HIV/AIDS and other health conditions: "disability" as defined under federal and state law. Journal of Health Care Law & Policy, 2000. 3(2): p. 266-329. 138. Wertheimer, S.M., Women and HIV testing in Canada: Barriers to testing as identified by service providers. Canadian Journal of Infectious Diseases and Medical Microbiology, 2011. 22: p. 97B. 139. Wesolowski, L.G., et al., Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS, 2006. 20(12): p. 1661-6. 140. Wesolowski, L.G., et al., Evaluation of Oral Fluid Enzyme Immunoassay for Confirmation of a Positive Rapid Human Immunodeficiency Virus Test Result. Clinical & Vaccine Immunology, 2009. 16(7): p. 1091-1092. 141. White, D.A.E., et al., Missed opportunities for earlier HIV diagnosis in an emergency department despite an HIV screening program. AIDS Patient Care & Stds, 2009. 23(4): p. 245-50. 142. Zachary, D., et al., Field comparison of OraQuick ADVANCE Rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infectious Diseases, 2012. 12: p. 183. 143. Zaw, M., et al., Local evaluation of a rapid HIV assay for use in developing countries. Tropical Medicine and International Health, 1999. 4(3): p. 216-221. 144. Zeh, C., et al., Performance of six commercial enzyme immunoassays and two alternative HIV-testing algorithms for the diagnosis of HIV-1 infection in Kisumu, Western Kenya. Journal of Virological Methods, 2011. 176(1-2): p. 24-31. 145. Zelin, J., et al., An evaluation of the performance of OraQuick(R) ADVANCE Rapid HIV- 1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK. International Journal of STD & AIDS, 2008. 19(10): p. 665-667. </p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    8 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us